Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity

NCT01538225 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Sativex®
DRUG: Placebo

Sponsor

Almirall, S.A.